Skip to main content
. 2019 Sep 12;157(2):427–434. doi: 10.1016/j.chest.2019.08.2187

Table 2.

Rates of Testing 12 Mo in the LDCT Cohort and in a Matched Control Cohort That Did Not Undergo LDCT

Test LDCT (n = 11,520)a Control Patients (n = 11,520)b Adjusted Rate (95% CIc)
Any chest imaging (not including LDCT) 20.66 (19.92-21.40) 6.90 (6.43-7.37) 13.76 (12.88-14.64)
Any chest imaging (including LDCT) 24.86 (24.07-25.65) 7.15 (6.68-7.63) 17.71 (16.78-18.64)
 CT 20.56 (19.81-21.30) 6.79 (6.32-7.25) 13.77 (12.89-14.65)
 PET/MRI 0.29 (0.18-0.39) 0.16 (0.08-0.23) 0.13 (0.00-0.26)
Any procedure 3.71 (3.36-4.06) 0.57 (0.43-0.72) 3.13 (2.75-3.51)
 Bronchoscopy 2.33 (2.05-2.61) 0.32 (0.21-0.43) 2.01 (1.70-2.31%)
 Percutaneous biopsy 1.48 (1.26-1.71) 0.19 (0.11-0.28) 1.29 (1.05-1.54)
 Mediastinoscopy 0.23 (0.14-0.33) 0.01 (0.00-0.03) 0.23 (0.13-0.32)
 Thoracoscopy 1.01 (0.82-1.19) 0.07 (0.02-0.12) 0.94 (0.74-1.13)
 Thoracotomy 0.43 (0.30-0.55) 0.04 (0.00-0.09) 0.38 (0.25-0.52)

Data are presented as percent (95% CI). See Table 1 legend for expansion of abbreviation.

a

LDCT cohort consisted of LDCT identified by Current Procedural Terminology codes G0297 or S8032. Enrollees were aged 55 to 80 y and had complete insurance coverage 12 mo after LDCT.

b

Control patients: among those patients with no LDCT scan in 2016, subjects were matched to the LDCT group by age, sex, and number of comorbidities.

c

95% CI for difference was calculated by Wald method.